NCT03661034View on ClinicalTrials.gov

Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2018

Primary Completion Date

May 1, 2021

Study Completion Date

March 1, 2022

Conditions
Alzheimer Disease, Early OnsetAlzheimer DiseaseAlzheimer DementiaMild Cognitive ImpairmentMemory DisordersMemory LossMemory ImpairmentMemory Disorders, Age RelatedAlzheimer Disease, Late OnsetCognitive ImpairmentDementia, MildDementia, Alzheimer TypeCognitive Decline
Interventions
DEVICE

GammaSense Stimulation System (non-invasive, non-significant risk)

Non-invasive, non-significant risk audio-visual sensory stimulation device

Trial Locations (1)

02459

Boston Center for Memory, Newton

Sponsors
All Listed Sponsors
lead

Cognito Therapeutics, Inc.

INDUSTRY

NCT03661034 - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) | Biotech Hunter | Biotech Hunter